Sec. 28.5. (a) This section applies to an individual contract or a group contract that is entered into, amended, or renewed after June 30, 2023.

     (b) As used in this section, “wearable cardioverter defibrillator” means a device that:

(1) is worn externally on an individual’s body;

(2) continually monitors and analyzes the individual’s heart rhythm; and

(3) delivers a shock to the heart when an abnormal heart rhythm is detected.

     (c) An individual contract or a group contract must provide coverage for a wearable cardioverter defibrillator, including the cost of the wearable cardioverter defibrillator, any necessary accessory, and ongoing monitoring services.

     (d) The coverage required under subsection (c) must be in accordance with a:

(1) local coverage determination; or

(2) national coverage determination;

as defined in 42 U.S.C. § 1395ff(f) for Medicare purposes.

     (e) The coverage required by this section may not be subject to an annual or lifetime limitation.

As added by P.L.190-2023, SEC.32.